ICAM1 and ovarian cancer: Thus in our samples, we have analyzed HLA-DP rs3077 (A/G), HLA-DQ rs3920 (A/G), and ICAM-1 rs281437 (C/T) SNPs in benign, borderline, malignant ovarian tumors’ patients, and normal controls.